Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
RISING PHARMACEUTICALS

RISING PHARMACEUTICALS Recalls

All product recalls associated with RISING PHARMACEUTICALS.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 821–840 of 4747 recalls

Warfarin Sodium Tablets (Rising Pharmaceuticals) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 15, 2023Nationwide• RISING PHARMACEUTICALS

Dermoplast Antibacterial Spray (Advantice Health) – Subpotent Drug (2023)

Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.

Class IIILow

FDAFeb 2, 2023Nationwide• Advantice Health, Llc

BIOPHEN Protein C Kit (Aniara) – Chemical Substance Warning (2023)

New warnings and precautionary statements on product labelling: Reagent 2 (R2) of BIOPHEN Protein C 5 contains the chemical substance - Cesium Chloride which changed classification and has become hazardous according to the CLP regulation ((EC) No 1272/2008) is suspected of damaging fertility

1...40 414243 44...238

Page 42 of 238Next

FDAFeb 1, 2023Nationwide• Aniara Diagnostica LLC

BioFire BCID2 Panel (BioFire) – Temperature Excursion (2023)

Due to temperature excursions with products (products being stored outside of the required temperature specifications) that may cause a reduction in performance. The temperature excursion was as a result of shipping delays.

FDAFeb 1, 2023Nationwide• BioFire Diagnostics, LLC

Dimension Tacrolimus Flex (Siemens) – Imprecision Issue (2023)

Siemens Healthineers has received customer complaints and confirmed imprecision for Quality Control (QC) and patient samples with Dimension Tacrolimus (TAC) lots GA2286, GA3047 and GA3171. The health consequences of erroneous patient results are major, since in a worst case scenario, a patient s tacrolimus dosing could be altered, resulting in potential organ failure and rejection (due to too low or no tacrolimus being administered) or toxicity (due to too much tacrolimus being administered). Siemens internal investigation of the Dimension TAC assay showed the worst case imprecision with patient samples at the low end of the Analytical Measurement Range (AMR). A patient sample at 2.0 ng/mL (2.6 nmol/L) recovered as 0.0 ng/mL (0.0 nmol/L) (100% negative bias), another patient sample at 2.1 ng/mL (2.7 nmol/L) recovered at 4.3 ng/mL (5.6 nmol/L) (103% positive bias).

FDAJan 30, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Atellica CH Triglycerides (Siemens) – Reagent Carryover (2023)

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

FDAJan 27, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Atellica CH Total Protein II (Siemens) – Reagent Carryover (2023)

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

FDAJan 27, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Atellica CH Triglycerides_2 (Siemens) – Reagent Carryover (2023)

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

FDAJan 27, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Atellica CH LDL Cholesterol (Siemens) – Reagent Carryover (2023)

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

FDAJan 27, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Clobetasol Propionate Cream (Lupin) - Subpotent Drug (2023)

Subpotent Drug: Low assay result observed during long-term stability testing.

Class IIILow

FDAJan 20, 2023Nationwide• Lupin Pharmaceuticals Inc.

Allopurinol Tablets (Preferred) - Foreign Substance (2023)

Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Class IIModerate

FDAJan 16, 2023IN• Preferred Pharmaceuticals, Inc.

Diltiazem Hydrochloride Capsules (Sun) - Impurity Failure (2023)

Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

Class IIModerate

FDAJan 13, 2023Nationwide• SUN PHARMACEUTICAL INDUSTRIES INC

Atellica IM Folate 700 Test Kit (Siemens) – Calibration Bias (2023)

Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.

FDAJan 9, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

ADVIA Centaur Folate 100 Test Kit (Siemens) – Calibration Bias (2023)

Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.

FDAJan 9, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

ADVIA Centaur Folate 500 Test Kit (Siemens) – Calibration Bias (2023)

Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.

FDAJan 9, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Atellica IM Folate 140 Test Kit (Siemens) – Calibration Bias (2023)

Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.

FDAJan 9, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Prochlorperazine Tablets (Jubilant) – Subpotent Drug (2022)

Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

Class IIILow

FDADec 27, 2022Nationwide• Jubilant Cadista Pharmaceuticals, Inc.

ADVIA Centaur HBeAg Test (Siemens) – Interference Risk (2022)

Anti-HBe2 (aHBe2) interference with the Hepatitis B e Antigen (HBeAg) Assay, leads to elevated or reactive Hepatitis B e Antigen (HBeAg) results on samples that are non-reactive when HBeAg testing follows aHBe2 testing, regardless of whether both tests are performed on the same sample

FDADec 22, 2022Nationwide• Siemens Healthcare Diagnostics, Inc.

Epi-Caine (Pine Pharmaceuticals) – Raw Material Discoloration (2022)

CGMP Deviations: Raw material recalled by repackager, due to discoloration.

Class IIModerate

FDADec 22, 2022Nationwide• Pine Pharmaceuticals, LLC

Ganciclovir Injection (Hikma) – Label Mix-up (2022)

Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

Class IIModerate

FDADec 16, 2022Nationwide• Hikma Pharmaceuticals USA Inc.